Pulse.

a daily field guide to health research that matters

◆ Console

‹ Sun · 8 Nov 2026
Standard addition

Real-World HER2 Testing Practices and Performance of HER2 immunohistochemistry in Non-Breast, Non-Gastroesophageal Solid Tumors: Experience at a Large U.S. Academic Institution.

HER2 testing practices vary widely in non-breast cancers, with implications for ensuring patients receive appropriate targeted treatments.

This PubMed-indexed study examined real-world her2 testing practices and performance of her2 immunohistochemistry in non-breast, non-gastroesophageal solid tumors: experience at a large u.s. academic institution. Hum Pathol 2026 Nov 7:106304.

What the study was

Study design
Retrospective real-world diagnostic cohort study
Population
Human participants or human evidence described in the PubMed abstract
Category
Genomics/Precision Medicine
Maturity
Validated
Journal
Human pathology

Why it surfaced

Retrospective real-world diagnostic cohort study with PubMed abstract evidence; scored conservatively for genomics/precision medicine relevance and evidence maturity.

A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.